Drawing for KAJADA

USPTO serial 79313568

KAJADA

Reviewed by CopyMark Law Group

Reg. 7423655Status 404
Filing date
Status date
Registration date
Jun 25, 2024
Examiner
MCNAMARA, SHANA MARIE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KAJADA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 12, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 12, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Jun 25, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 25, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 22, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 9, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 9, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 20, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 20, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 20, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 31, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 4, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 4, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 4, 2022FINAFINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Oct 3, 2022CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Jul 18, 2022CRTPREG. CANCELLED - RESTORED TO PENDENCY—
Jul 12, 2022APETASSIGNED TO PETITION STAFF—
Jun 13, 2022RCIIREQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED—
Feb 3, 2022GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jan 4, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 19, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 19, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 29, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 16, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 6, 2021DOCKASSIGNED TO EXAMINER—
Jul 31, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jul 9, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 9, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 9, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 9, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 9, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 9, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 2, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 28, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 26, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 17, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance